| Financial Year |
March 31 2023 |
| Monetary Funds |
390,707,283.71 |
| Held-for-trading Financial Assets |
15,351,762.59 |
| Notes Receivable |
67,834,596.57 |
| Accounts Receivable |
1,473,176,427.94 |
| Advances to Suppliers |
647,203,922.26 |
| Other Receivables |
25,675,904.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,006,746,394.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
71,688,766.80 |
| Total Current Assets |
3,862,488,972.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
28,467,306.03 |
| Investment Properties |
-- |
| Fixed Assetes |
144,428,962.13 |
| Under-construction Projects |
117,736,262.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
23,996,100.93 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,065,849.85 |
| Deferred Income Tax Assets |
47,811,403.87 |
| Other Non-Current Assets |
5,140,057.13 |
| Sub-Total of Non-Current Assets |
471,841,552.05 |
| Total Assets |
4,334,330,524.21 |
| Short-Term Loans |
923,817,936.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
27,819,702.81 |
| Accounts Payable |
473,716,481.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,460,554.66 |
| Taxes Payable |
31,001,154.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,960,453.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,154,493.80 |
| Other Current Liabilities |
80,652,845.20 |
| Sub-Total of Current Liabilities |
2,173,442,805.07 |
| Long-term Loans |
5,415,747.98 |
| Bonds Payable |
373,005,652.31 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,788,548.28 |
| Deferred Income Tax Liabilities |
25,747,137.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
426,651,441.03 |
| Total Liabilities |
2,600,094,246.10 |
| Paid-In Capital(Or Share Stock) |
630,000,000.00 |
| Capital Surplus |
80,263,923.39 |
| Surplus Reserve |
64,456,193.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
898,323,669.20 |
| Minority Stockholder's Interest |
16,119,782.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,718,116,495.26 |
| Owner's Equity（Stockholder's Equity） |
1,734,236,278.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,334,330,524.21 |
